INFU logo

INFUSYSTEM HOLDINGS INC

INFUNYSE AMERICAN
๐Ÿ† #3035 by market capEarnings Nov 2 ยท PreUS Equity
$12.46โ–ฒ $0.35 (+2.81%)
๐ŸŒ… Pre-market$12.46โ–ฒ 0.00%Regular close ยท extended-hours price shown
1hโ€”
24hโ–ฒ 2.8%
7dโ–ฒ 2.8%
14dโ–ฒ 27.8%
30dโ–ฒ 33.5%
1yโ–ฒ 32.7%
๐ŸฆMarket Cap
$251M
Small Cap
๐Ÿ“ˆRevenue Growth (YoY)
+3.5%
Slowing
๐Ÿ“ŠGross Margin
56.8%
Healthy
๐Ÿ’ตFCF Margin
12.2%
Healthy
โš–๏ธP/S Ratio
1.7x
Cheap
Otter Score
44
Weak

Trading Snapshot

Day Range
$12.36 โ€“ $12.52
52-Week Range
$7.29 โ€“ $12.97
Volume
$2.43B
Avg Volume
$2.82B
Shares Outstanding
20.2M
Next Earnings
Oct 25, 2026

Fundamentals Snapshot

Annual Revenue
$143M
Last Q Revenue
$37M
P/E Ratio
31.4
P/S Ratio
1.7x
EPS (TTM)
$0.38
Dividend Yield
โ€”

Why Investors Own INFU

  • โœ“High-growth profile โ€” revenue up +12.2% YoY with expanding US Equity exposure.
  • โœ“Healthy economics โ€” 58% gross margin and 24% free-cash-flow margin.
  • โœ“New products and segments could unlock additional revenue streams.
โš ๏ธ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$143Mโ–ฒ +13.5% YoY
Gross Margin (TTM)
57.9%โ–ฒ +2.7% YoY
Operating Income (TTM)
$41Mโ–ฒ +13.5% YoY
Free Cash Flow (TTM)
$35Mโ–ฒ +13.5% YoY

About INFUSYSTEM HOLDINGS INC

InfuSystem Holdings, Inc. delivers infusion pumps, along with associated products and support services, to clients across the United States and Canada. The enterprise operates through two principal divisions: Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). The ITS segment specializes in providing electronic ambulatory infusion devices and accompanying disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy facilities. These devices are crucial for managing various cancers, including colorectal cancer, as well as for pain management and other therapeutic needs. Moreover, the company markets, leases, and rents out a selection of new and pre-owned infusion pumps (both pole-mounted and ambulatory) and other vital durable medical equipment. It also sells consumables essential for treatment. InfuSystem further extends its offerings to include biomedical recertification, maintenance, and repair services for oncology practices and diverse alternative care settings, such as home care and home infusion providers, skilled nursing facilities, pain centers, and hospitals. Additionally, InfuSystem furnishes both local and field-based customer assistance and manages dedicated pump service and repair facilities. The company was founded in 2005 and maintains its corporate headquarters in Rochester Hills, Michigan.

๐Ÿฆฆ

Otter Score Breakdown

โ“˜
๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿš€Growthโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
โšกMomentumโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Weak
44/100

Analyst Ratings

โ“˜
Consensus
Buy
10 analysts
Strong Buy3
Buy6
Hold1
Sell0
Strong Sell0
Ratings as of Aug 2026

Latest News & Updates

SeekingAlphaยท6d ago

Diamond Hill Small Cap Fund Q2 2026 Portfolio Activity

Astrana Health outperformed as the company results have continued to demonstrate that it was not taking advantage of loopholes within Medicare coding.

๐Ÿ›ฐ๏ธ
Benzingaยท6d ago

B. Riley Securities Reiterates Buy on InfuSystems Holdings, Raises Price Target to $20

B. Riley Securities analyst Anderson Schock reiterates InfuSystems Holdings (AMEX:INFU) with a Buy and raises the price target from $12 to $20.

SeekingAlphaยท7d ago

InfuSystem Holdings, Inc. (INFU) Q2 2026 Earnings Call Transcript

InfuSystem Holdings, Inc. (INFU) Q2 2026 Earnings Call August 4, 2026 9:00 AM EDTCompany ParticipantsCarrie Lachance - President, CEO & DirectorBarry...

Benzingaยท7d ago

12 Health Care Stocks Moving In Tuesday's Intraday Session

Gainers Autonomix Medical (NASDAQ:AMIX) stock rose 415.3% to $18.81 during Tuesday's regular session. The company's market cap stands at $1.9 million. Adagio Medical Holdings (NASDAQ:ADGM) shares increased by

ChartMillยท8d ago

InfuSystem Holdings (NYSEARCA:INFU) Shares Jump After Q2 Earnings Beat

InfuSystem (INFU) Q2 EPS beats at $0.15 vs $0.11 est, revenue nearly in line; shares rise ~4.7% premarket on margin gains.

Benzingaยท8d ago

InfuSystems Holdings Reports Q2 2026 Results: Full Earnings Call Transcript

InfuSystems Holdings (AMEX:INFU) reported second-quarter financial results on Tuesday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered by Benzinga